Sotuvning operatsion marjasi: MiNK Therapeutics Inc. (INKT)

MiNK Therapeutics, Inc (INKT) kompaniyasining korporativ logotipi

MiNK Therapeutics, Inc. (INKT) hujayra platformalarining yuqori kengayish salohiyati kelgusida bozorga millionlab hamyonbop dozalarni yetkazib berish imkonini beradi. Operatsion marja samaradorlik dinamikasini aks ettiradi, bunda -6006.20 joriy ko'rsatkichni ifodalaydi. Dorilar ishlab chiqarish AQSh CDMO zavodlari va Massachusets laboratoriyalari bilan hamkorlikka tayanadi, kompaniya esa qimmat klinika sinovlarini o'tkazish uchun tizimli ravishda likvidlikdan foydalanmoqda.

INKT: minktherapeutics.com Operatsion foyda normasi 04.07.2022 - 20.11.2026

MiNK Therapeutics, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (INKT)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:INKT, MiNK Therapeutics
MiNK Therapeutics, Inc asosiy tovari

Yuqori sifatli portfelni shakllantirish uchun men operatsion marjani samaradorlik koeffitsiyenti sifatida foydalanaman, u asosiy jarayonlardan olingan sof foyda ulushini baholash uchun operatsion daromadni umumiy tushumga bo'lish orqali hisoblanadi. MiNK Therapeutics, Inc. (INKT) holatida, operatsion marja vaqtlar ketma-ketligi kompaniyaning hujayralar terapiyasi sohasidagi ilmiy ittifoqlarni monetizatsiya qilish qobiliyatini aks ettirib, fundamental o'sishni ishlab chiqish xarajatlaridan ajratadi.

MiNK Therapeutics, Inc. kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Compass Therapeutics - Operatsion foyda normasi|REPL (replimune.com) - Operatsion marja|Operatsion marja Lyell|Operatsion rentabellik Innate Pharma (IPHA)|PYXS: Operatsion foyda marjasi|Compugen - Sotuvning operatsion marjasi|IO Biotech, Inc. (IOBT) - Sotuvning operatsion rentabelligi|STRO - Operatsion rentabellik|werewolftx.com (HOWL) - Sotuvning operatsion marjasi|Immix (IMMX) - Operatsion rentabellik|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja